Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Pfizer Study Shows Bivalent Boosters Offer No Short-Term Superiority

Pfizer Study Shows Bivalent Boosters Offer No Short-Term Superiority

-Reuters

byBenzinga Newsdesk

October 25, 2022

1 minute read

-Reuters

Ethereum Drops Below This Key Level; XDC Network Emerges As Top Gainer

By Lisa Levin

December 15, 10:49 AM

Bitcoin (CRYPTO: BTC), the most valued cryptocurrency in the world, recorded losses, but traded above the key $17,000 level on Thursday. Ethereum (CRYPTO: ETH), also traded lower, falling below the $1,300 level.

$BSV

Fortinet, Apollo Global Management And A Major Casino Operator On CNBC’s ‘Final Trades’

By Lisa Levin

November 9, 10:10 AM

On CNBC’s "Halftime Report Final Trades," Stephanie Link of Hightower named Fortinet, Inc. (NASDAQ: FTNT) as her final trade.

APO

SoFi Q2 Earnings Highlights: Revenue And EPS Beat, Record Revenue And 450K New Members Lead To Raised Full Year Guidance

By Chris Katje

August 2, 5:54 PM

Financial services company SoFi Technologies Inc (NASDAQ: SOFI) reported second-quarter financial results after market close Tuesday. Here are the key highlights.

SOFI

CMS Says Updated Covid-19 Vaccines Providing Protection Against Omicron Variant Available At No Cost

By Benzinga Newsdesk

September 12, 11:09 AM

- Reuters

AZN

Pfizer Study Shows Bivalent Boosters Offer No Short-Term Superiority

Related Posts

Ethereum Drops Below This Key Level; XDC Network Emerges As Top Gainer

Fortinet, Apollo Global Management And A Major Casino Operator On CNBC’s ‘Final Trades’

SoFi Q2 Earnings Highlights: Revenue And EPS Beat, Record Revenue And 450K New Members Lead To Raised Full Year Guidance

CMS Says Updated Covid-19 Vaccines Providing Protection Against Omicron Variant Available At No Cost